Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,056 | -10,880 | -11,172 | -8,843 | -4,873 |
| Depreciation Amortization | 1,407 | 5,729 | 4,411 | 3,008 | 1,592 |
| Income taxes - deferred | 108 | -7 | 18 | 15 | 18 |
| Accounts receivable | -2,180 | 408 | 1,953 | 659 | 3,034 |
| Accounts payable and accrued liabilities | 745 | 42 | -835 | -1,066 | 47 |
| Other Working Capital | -9,187 | -823 | 308 | -4,102 | -269 |
| Other Operating Activity | 9,317 | 16,719 | 11,868 | 10,010 | 321 |
| Operating Cash Flow | $-4,846 | $11,188 | $6,551 | $-319 | $-130 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 192 | 1,329 | 483 | 328 | N/A |
| PPE Investments | -1,431 | -6,226 | -5,578 | -3,691 | 1,672 |
| Net Acquisitions | N/A | 4,496 | 4,496 | 4,496 | N/A |
| Investing Cash Flow | $-1,239 | $-401 | $-599 | $1,133 | $1,672 |
| Cash Flows From Financing Activities | |||||
| Common Stock Repurchased | -8,690 | -9,485 | -3,971 | -3,971 | -3,971 |
| Other Financing Activity | -1,657 | -1,066 | -1,301 | -1,288 | -1,467 |
| Financing Cash Flow | $-10,347 | $-10,551 | $-5,272 | $-5,259 | $-5,438 |
| Exchange Rate Effect | -29 | 86 | 151 | 453 | 108 |
| Beginning Cash Position | 57,481 | 57,159 | 57,159 | 57,159 | 57,159 |
| End Cash Position | 41,020 | 57,481 | 57,990 | 53,167 | 53,371 |
| Net Cash Flow | $-16,461 | $322 | $831 | $-3,992 | $-3,788 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,846 | 11,188 | 6,551 | -319 | -130 |
| Capital Expenditure | -1,431 | -6,826 | -6,178 | -4,291 | -2,824 |
| Free Cash Flow | -6,277 | 4,362 | 373 | -4,610 | -2,954 |